U.S. advances first government-funded trials of psychedelic drug ibogaine

Ibogaine Trials Would Call for Inpatient Care and Up to 36 Hours of Heart Monitoring Under FDA Proposal

FDA wants ibogaine trials run in inpatient units with continuous heart monitoring because the unapproved drug can trigger dangerous heart rhythms.

Pharmalittle: We're reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more

AstraZeneca's pivot towards the U.S. market has continued with the opening of a new R&D center in the biotech hotspot of Cambridge, Mass.

First Government-Funded Psychedelic Drug Trial

US advances first government-funded trials of psychedelic drug ibogaine - Regional Media News

By Kamal Choudhury Oct 5 (Reuters) - US health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder, the FDA said on Monday, as it sought public feedback on safety rules for the studies. The initiative follows an April executive order by President Donald Trump, dedicating $50 million to the federal ibogaine research, as well as recent cal…

U.S. advances first government-funded trials of psychedelic drug ibogaine

U.S. health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder.

US advances first government-funded trials of psychedelic drug ibogaine

Oct 5 (Reuters) - US health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder, ​the FDA said on Monday, as it sought ‌public feedback on saf...